135 related articles for article (PubMed ID: 25655849)
1. Prevention of recurrent cryptogenic stroke with percutaneous closure of patent foramen ovale; one year follow-up study with magnetic resonance imaging and Holter monitoring.
Ateş AH; Sunman H; Aytemir K; Yorgun H; Canpolat U; Topcuoğlu MA; Karlı Oğuz K; Şahiner L; Kaya EB; Tokgözoğlu L; Kabakçı G; Oto A
Turk Kardiyol Dern Ars; 2015 Jan; 43(1):38-46. PubMed ID: 25655849
[TBL] [Abstract][Full Text] [Related]
2. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
Vigna C; Inchingolo V; Giannatempo G; Pacilli MA; Di Viesti P; Fusilli S; Amico CM; Santoro T; Lanna P; Fanelli R; Simone P; Loperfido F
Am J Cardiol; 2008 Apr; 101(7):1051-5. PubMed ID: 18359330
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
4. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
[TBL] [Abstract][Full Text] [Related]
5. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
[TBL] [Abstract][Full Text] [Related]
6. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
[TBL] [Abstract][Full Text] [Related]
7. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
8. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Davies A; Ekmejian A; Collins N; Bhagwandeen R
Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound.
Devuyst G; Bogousslavsky J; Ruchat P; Jeanrenaud X; Despland PA; Regli F; Aebischer N; Karpuz HM; Castillo V; Guffi M; Sadeghi H
Neurology; 1996 Nov; 47(5):1162-6. PubMed ID: 8909423
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
12. Surgical prophylaxis of recurrent stroke in patients with patent foramen ovale: a pilot study.
Guffi M; Bogousslavsky J; Jeanrenaud X; Devuyst G; Sadeghi H
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):260-3. PubMed ID: 8751488
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
Pickett CA; Villines TC; Ferguson MA; Hulten EA
Am J Cardiol; 2014 Nov; 114(10):1584-9. PubMed ID: 25248812
[TBL] [Abstract][Full Text] [Related]
14. Ten years of experience with closure of persistent foramen ovale: patient characteristics and outcomes.
Lehmann R; Fichtlscherer S; Baldauf H; Schächinger V; Auch-Schwelck W; Zeiher AM; Teupe C
J Cardiol; 2014 Aug; 64(2):113-6. PubMed ID: 24480741
[TBL] [Abstract][Full Text] [Related]
15. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience.
Węglarz P; Konarska Kuszewska E; Spisak Borowska K; Machowski J; Drzewiecka-Gerber A; Kuszewski P; Jackson CL; Opala G; Trusz Gluza M
Kardiol Pol; 2012; 70(5):478-84. PubMed ID: 22623240
[TBL] [Abstract][Full Text] [Related]
17. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
[TBL] [Abstract][Full Text] [Related]
18. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes and Quality of Life after Patent Foramen Ovale (PFO) Closure in Patients with Stroke/Transient Ischemic Attack of Undetermined Cause and Other PFO-Associated Clinical Conditions: A Single-Center Experience.
Evola S; Camarda EA; Triolo OF; Adorno D; D'Agostino A; Novo G; Onorato EM
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762729
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
